Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects
The DOI matches its Crossref record.
Abstract
We compared the effects of oral vanadyl sulfate (100 mg/day) in moderately obese NIDDM and nondiabetic subjects. Three-hour euglycemic-hyperinsulinemic (insulin infusion 30 mU · m−2 · min−1) clamps were performed after 2 weeks of placebo and 3 weeks of vanadyl sulfate treatment in six nondiabetic control subjects (age 37 ± 3 years; BMI 29.5 ± 2.4 kg/m2) and seven NIDDM subjects (age 53 ± 2 years; BMI 28.7 ±1.8 kg/m2). Glucose turnover ([3-3H]glucose), glycolysis from plasma glucose, glycogen synthesis, and whole-body carbohydrate and lipid oxidation were evaluated. Decreases in fasting plasma glucose (by ∼1.7 mmol/l) and HbAlc (both P < 0.05) were observed in NIDDM subjects during treatment; plasma glucose was unchanged in control subjects. In the latter, the glucose infusion rate (GIR) required to maintain euglycemia (40.1 ± 5.7 and 38.1 ± 4.8 μmol · kg fat-free mass [FFM]−1 · min−1) and glucose disposal (Rd) (41.7 ± 5.7 and 38.9 ±4.7 μmol · kg FFM−1 · min−1) were similar during placebo and vanadyl sulfate administration, respectively. Hepatic glucose output (HGO) was completely suppressed in both studies. In contrast, in NIDDM subjects, vanadyl sulfate increased GIR ∼82% (17.3 ± 4.7 to 30.9 ± 2.7 μmol · kg FFM−1 · min−1, P < 0.05); this improvement in insulin sensitivity was due to both augmented stimulation of Rd (26.0 ±4.0 vs. 33.6 ± 2.22 μmol · kg FFM−1 · min−1, P < 0.05) and enhanced suppression of HGO (7.7 ± 3.1 vs. 1.3 ± 0.9 μmol · kg FFM−1 · min−1, P < 0.05). Increased insulin-stimulated glycogen synthesis accounted for >80% of the increased Rd with vanadyl sulfate (P < 0.005), but plasma glucose flux via glycolysis was unchanged. In NIDDM subjects, vanadyl sulfate was also associated with greater suppression of plasma free fatty acids (FFAs) (P < 0.01) and lipid oxidation (P < 0.05) during clamps. The reduction in HGO and increase in Rd were both highly correlated with the decline in plasma FFA concentrations during the clamp period (P < 0.001). In conclusion, small oral doses of vanadyl sulfate do not alter insulin sensitivity in nondiabetic subjects, but it does improve both hepatic and skeletal muscle insulin sensitivity in NIDDM subjects in part by enhancing insulin's inhibitory effect on lipolysis. These data suggest that vanadyl sulfate may improve a defect in insulin signaling specific to NIDDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Crans, D. C., Smee, J. J., Gaidamauskas, E., & Yang, L. (2004) · Chemical Reviews · doi:10.1021/cr020607t · Cited by 1,364
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
Antidiabetic vanadium(IV) and zinc(II) complexes
Sakurai, H., Kojima, Y., Yoshikawa, Y., Kawabe, K., & Yasui, H. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00447-7 · Cited by 537
Vanadium treatment of type 2 diabetes: A view to the future
Thompson, K. H., Lichter, J., LeBel, C., Scaife, M. C., McNeill, J. H., & Orvig, C. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.12.003 · Cited by 520
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Thompson, K. H., & Orvig, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.08.016 · Cited by 508
ISSN exercise & sport nutrition review: research & recommendations
Kreider, R. B., Wilborn, C. D., Taylor, L., Campbell, B., Almada, A. L., Collins, R., Cooke, M., Earnest, C. P., Greenwood, M., Kalman, D. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-7 · Cited by 428
“daily [246,247], vanadyl sulfate supplementation does”
Ezuruike, U. F., & Prieto, J. M. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.05.055 · Cited by 401
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
Matthaei, S., Stumvoll, M., Kellerer, M., & Häring, H.-U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0413 · Cited by 377
Treviño, S., Díaz, A., Sánchez-Lara, E., Sanchez-Gaytan, B. L., Perez-Aguilar, J. M., & González-Vergara, E. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1540-6 · Cited by 354
Alternative therapies useful in the management of diabetes: A systematic review
Tripathi, P., Pandey, A., Pandey, R., Srivatava, R., & Goswami, S. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.90103 · Cited by 298
Mechanick, J. I., Brett, E. M., Chausmer, A. B., Dickey, R. A., Wallach, S., Bergman, D. A., Garber, J. R., Hamilton, C. R., Handelsman, Y., Holdy, K. E., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.5.417 · Cited by 73
Metadata
- Authors
- Halberstam, M., Cohen, N., Shlimovich, P., Rossetti, L., & Shamoon, H.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1996-05-01
- Volume
- 45
- Issue
- 5
- Pages
- 659-666
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2058307795
- Cited by
- 187
- References
- 0
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.